IMEX   05356
INSTITUTO DE MEDICINA EXPERIMENTAL
Unidad Ejecutora - UE
artículos
Título:
Neutrophil extracellular trap formation and circulating nucleosomes in patients with chronic myeloproliferative neoplasms
Autor/es:
LEV, PAOLA R.; MOIRAGHI, BEATRIZ; SCHATTNER, MIRTA; MARIN OYARZÚN, CECILIA P.; CARESTIA, AGOSTINA; GLEMBOTSKY, ANA C.; CASTRO RÍOS, MIGUEL A.; MOLINAS, FELISA C.; MARTA, ROSANA F.; HELLER, PAULA G.; LEV, PAOLA R.; MOIRAGHI, BEATRIZ; SCHATTNER, MIRTA; CARESTIA, AGOSTINA; CASTRO RÍOS, MIGUEL A.; MARTA, ROSANA F.; MARIN OYARZÚN, CECILIA P.; GLEMBOTSKY, ANA C.; MOLINAS, FELISA C.; HELLER, PAULA G.
Revista:
Scientific reports
Editorial:
Nature Publishing Group,
Referencias:
Año: 2016 vol. 6
ISSN:
2045-2322
Resumen:
The mechanisms underlying increased thrombotic risk in chronic myeloproliferative neoplasms (MPN) are incompletely understood. We assessed whether neutrophil extracellular traps (NETs), which promote thrombosis, contribute to the procoagulant state in essential thrombocythemia, polycythemia vera and myelofibrosis (MF) patients. Although MPN neutrophils showed increased basal reactive oxygen species (ROS), enhanced NETosis by unstimulated neutrophils was an infrequent finding, whereas PMA-triggered NETosis was impaired, particularly in MF, due to decreased PMA-triggered ROS production. Elevated circulating nucleosomes were a prominent finding and were higher in patients with advanced disease, which may have potential prognostic implication. Histone-MPO complexes, proposed as specific NET biomarker, were seldomly detected, suggesting NETs may not be the main source of nucleosomes in most patients, whereas their correlation with high LDH points to increased cell turn-over as a plausible origin. Lack of association of nucleosomes or NETs with thrombosis or activation markers does not support their use as predictors of thrombosis although prospective studies in a larger cohort may help define their potential contribution to MPN thrombosis. These results do not provide evidence for relevant in vivo NETosis in MPN patients under steady state conditions, although availability of standardized NET biomarkers may contribute to further research in this field.